Loading page content
Sam Bourgi is an analyst, writer and financial market commentator featured in and cited by U.S. Congress, Department of Justice, Chicago Board Options Exchange, Barron's and Forbes. He covers stocks, bonds, mutual funds, ETFs, forex, Bitcoin, cryptocurrency, real estate and macroeconomics. He has written over 25,000 articles and over 40 whitepapers and e-books.
Sigmacast expected range · 7–28-day calibrated zone
Forecast batch: 9/20/26
Premium grade: 2026-09-20 05:05 UTC
MRNA's calibrated band puts the expected move at ±6.4% over 7 days, widening to ±14.9% over 28. Options are currently pricing in line with the band (VRP ≈ 1.01×) — premium screens fair on this scale. That grade is the same at all three horizons — each one's band is below.
Nested 60 / 80 / 95 calibrated expected-range · centered on current price (gold tick)
Macro correlations · context (not confirmation)
8 correlated indicators
Observed historical correlations, not forward signals.
Positively correlated: Total Vehicle Sales (r=+0.88), All Car Sales (r=+0.75), Labor Force Participation Rate (r=+0.73)
Inversely correlated: Non Defense Goods Orders Ex Air (r=-0.89), Richmond Fed Services Revenues Index (r=-0.81), Producer Price Index (r=-0.74), PCE Price Index MoM (r=-0.73), 5-Year Note Auction (r=-0.72)
As of September 20, 2026, MRNA is trading at 154.01. Our multi-model Sigmanomics forecast for this stock generates expected price ranges (magnitude, not direction) across 7-day, 14-day, and 28-day horizons, each with a recent-path character readout. Based on ensemble models including SIGMACAST, Σ-Adaptive, and Σ-Trend with model-agreement confidence bands. Updated daily.
Containment = how often the band held (backtest) — magnitude only, not a directional record.
Forecasts generated by Sigmanomics engine. Not financial advice.
Moderna, Inc. ADR (MRNA) is a publicly traded stock covered by the Sigmanomics analytics platform. The MRNA stock closed at 154.01 on September 18, 2026, reflecting a decline of 2.53% from the previous close of 158.01. MRNA is listed on the BCBA in Argentina.
Over the past 30 days, the stock has experienced a strong uptrend with a rally of 160.28%, ranging between 54.6300 and 176.66. The price currently trades above its 20-day moving average of 145.89. The 14-day RSI stands at 63.2, in the upper part of its range.
Over the same 30-day window, daily-return volatility was 32.88%, reflecting heightened price variability for this stock. Across the past 52 weeks, the stock has traded between 22.2900 and 176.66, with the current price near the high end of that range.
Daily-return volatility of 32.88% runs elevated for this stock, so price ranges are likely to stay wide — watch how price behaves around its recent range rather than treating any single level as fixed. MRNA is currently trading 5.57% above its 20-day moving average and sitting in the upper portion of its 52-week range. Its 14-day RSI reads 63.2, currently in neutral territory.
Auto-generated from Sigmanomics market data. Last update Sep 2026.
Sigmacast forecasts span six horizons — 30-minute, 1-hour, 2-hour, 4-hour, 12-hour, and daily — refreshed continuously as new bars arrive.